UBS Reiterates Buy Rating on Acadia Healthcare (ACHC); Q3, FY25 Estimates Adjusted
Tweet Send to a Friend
UBS analyst AJ Rice reiterated a Buy rating and $31.00 price target on Acadia Healthcare (NASDAQ: ACHC).The analyst commented, "In ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
